Literature DB >> 15385082

Animal models of inflammatory bowel disease.

Abdo R Jurjus1, Naim N Khoury, Jean-Marie Reimund.   

Abstract

In inflammatory bowel disease (IBD), experimental models have proven to be important tools for detecting potential therapeutic agents and for investigating the mechanisms of pathogenesis. This review is intended to cover recent advances in basic IBD model applications. The use of more than 20 animal models has allowed the detection of numerous protective pharmacological agents, including a number of immunomodulatory agents that have entered the therapeutic armamentarium. The models have been classified into five main categories based on the methods of induction: gene knockout (KO), transgenic, chemical, adoptive transfer, and spontaneous (each with subcategories).

Entities:  

Mesh:

Year:  2004        PMID: 15385082     DOI: 10.1016/j.vascn.2003.12.002

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  96 in total

1.  Protective effect of aqueous extract of Spinacia oleracea leaves in experimental paradigms of inflammatory bowel disease.

Authors:  Kishor Vasant Otari; Priyanka Subhash Gaikwad; Rajkumar Virbhadrappa Shete; Chandrashekhar Devidas Upasani
Journal:  Inflammopharmacology       Date:  2012-01-11       Impact factor: 4.473

2.  Normal hematologic and serum biochemical values of cotton-top tamarins (Saguinus oedipus).

Authors:  Evan T Shukan; Carla Y Boe; Aimee V Hasenfus; Bridget A Pieper; Charles T Snowdon
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

Review 3.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

4.  High incidence of inflammatory bowel disease with improved hygiene and failure to get human-like IBD in laboratory animals.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

Review 5.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 6.  Autoantibodies and an immune-based rat model of inflammatory bowel disease.

Authors:  Hadi Esmaily; Yara Sanei; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

7.  Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.

Authors:  Fermín Capitán-Cañadas; Borja Ocón; Carlos José Aranda; Andrea Anzola; María Dolores Suárez; Antonio Zarzuelo; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

8.  Induction of murine TNBS colitis is strictly controlled by a modified method using continuous inhalation anesthesia with sevoflurane.

Authors:  Tomohiro Terai; Satoshi Osawa; Shinya Tani; Shinji Oishi; Yoshifumi Arai; Takanori Yamada; Mitsushige Sugimoto; Takahisa Furuta; Shigeru Kanaoka; Hiroaki Miyajima; Ken Sugimoto
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

9.  Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice.

Authors:  Fang Zhao; Robert Edwards; Diana Dizon; Kambiz Afrasiabi; Jennifer R Mastroianni; Mikhail Geyfman; André J Ouellette; Bogi Andersen; Steven M Lipkin
Journal:  Dev Biol       Date:  2009-12-16       Impact factor: 3.582

10.  Inflammation and proliferation act together to mediate intestinal cell fusion.

Authors:  Paige S Davies; Anne E Powell; John R Swain; Melissa H Wong
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.